The Mycobacterium tuberculosis Rv1099c gene encodes a GlpX-like class II fructose 1,6-bisphosphatase

Area of Science:

• Microbiology
• Biochemistry
• Molecular Biology

Background:

• Mycobacterium tuberculosis extensively utilizes fatty acids as a carbon source during infection.
• A critical enzyme in gluconeogenesis, fructose 1,6-bisphosphatase (FBPase), was initially absent from the M. tuberculosis genome annotation.
• Understanding M. tuberculosis metabolism is vital for developing new anti-tubercular therapies.

Purpose of the Study:

• To identify and characterize the missing fructose 1,6-bisphosphatase (FBPase) enzyme in Mycobacterium tuberculosis.
• To investigate the role of the Rv1099c gene product in M. tuberculosis metabolism.

Main Methods:

• Complementation of an Escherichia coli FBPase-deficient mutant with the M. tuberculosis Rv1099c gene.
• Biochemical assays to confirm FBPase activity of the Rv1099c protein.
• Analysis of Rv1099c gene expression levels in M. tuberculosis.

Main Results:

• The M. tuberculosis Rv1099c gene, a glpX homologue, successfully complemented E. coli mutants lacking FBPase.
• The protein encoded by Rv1099c demonstrated significant fructose 1,6-bisphosphatase activity.
• Rv1099c is expressed at high levels in M. tuberculosis, suggesting it is a major FBPase.

Conclusions:

• Rv1099c encodes a functional fructose 1,6-bisphosphatase (FBPase) in Mycobacterium tuberculosis.
• This enzyme plays a significant role in the gluconeogenic pathway of M. tuberculosis.
• The identification of this FBPase provides a potential new target for anti-tubercular drug development.